The goal of this NIIMBL project is to align this powerful technology with the most urgent needs of biopharma. This will include evaluating assay performance with Tier 1 partner samples. In addition, based on input from working groups with Tier 1 partners, we will determine the optimal software tools required for analysis of the resulting cIEF and...
Our Network @ Work
Learn more about the 91¿´Æ¬ network of institutes and the real-world results their work delivers every day.

NIIMBL: Education and Training Resources

Automated bioprocess test beds will be designed and implemented across three sites. Each test bed will consist of process S ensors and software for P rocess control, I ntegration, D ata analysis, process E volution, and R eporting. The test beds in the SPIDER Network will be used for training that addresses automation topics relevant to engineering...

Researchers in Carnegie Mellon University's are collaborating with leading biotechnology company , a member of the Roche Group, and , a biotechnology instrumentation company based in Charlottesville, Virginia, to develop an advanced biomanufacturing technology for adventitious agent testing, or...

On Veterans Day, we thought it important to reflect upon the significance of the holiday and the role our work plays in supporting the men and women who served their country honorably. Military members who raise their hand and pledge to defend the freedom’s we enjoy endure great risk. For too many, this risk of harm becomes a reality. ARMI |...